Study Evaluation LXR-623 in Healthy Adults
NCT00379860 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2007-03-09
Summary
To evaluate the safety and tolerability of multiple doses of LXR in healthy adults.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
LXR-623
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
- Completion
- 2007-01-31
More Related Trials
-
Study to Determine the Safety, Tolerability and Pharmacokinetics Following Multiple Doses of LX4211 in Healthy Subjects
NCT01916850 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses
NCT00909688 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3871801 in Healthy Participants
NCT05222399 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants
NCT06049095 ·Status: RECRUITING ·Phase: PHASE1
-
Study Evaluating Single Doses of BLI-489 in Healthy Subjects
NCT00820404 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants
NCT07271693 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase 1 Dose Escalation Study of VX-993 in Healthy Participants
NCT05653323 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects
NCT00796965 ·Status: COMPLETED ·Phase: PHASE1
-
ANX-042 Healthy Volunteer Dose Escalation Study
NCT01638104 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Safety of FXR-450 in Healthy Subjects
NCT00499629 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants
NCT06356259 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants
NCT07039929 ·Status: TERMINATED ·Phase: PHASE1
-
Multiple Ascending Oral Dose 14-Day Trial of LHF-535 in Healthy Participants
NCT03993704 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of LY3372689 in Healthy Participants
NCT04106206 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults
NCT06394167 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of RG7625 in Healthy Volunteers
NCT02295332 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of LY3372689 Given By Mouth to Healthy Participants
NCT03819270 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of ELX-02 in Healthy Adults
NCT03292302 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of LY3526318 in Healthy Participants
NCT04682119 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
NCT05658107 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
NCT01348165 ·Status: TERMINATED ·Phase: PHASE1
-
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
NCT01162889 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 1 Study of ELX-02 in Healthy Adult Subjects
NCT03309605 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects
NCT00447681 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety of ARGX-109 in Healthy Volunteers
NCT06799416 ·Status: COMPLETED ·Phase: PHASE1